Friday, July 10, 2026

Intelligence · Clinical pipeline

Infectious disease R&D Pipeline

Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Programs 1,112

Quick answer

Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Top sponsors

Pipeline programs

Page 20 of 24
  1. AB.OH.2025

    The George Institute

    Infectious diseases

    approved small molecule active

    1 trial
  2. AL (Coartem)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  3. AMOXICILINA NORMON 1000 mg Comprimidos EFG

    The George Institute

    Infective endocarditis

    approved small molecule active

    1 trial
  4. AZD1222

    AstraZeneca

    COVID-19, SARS-CoV-2

    approved mab terminated

    1 trial
  5. Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial
  6. Adult group in immunogenicity and safety study of combined immunization

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  7. Aerosolized 13 cis retinoic acid plus Vitamin D

    The First People's Hospital of Lianyungang

    Post COVID-19 Anosmia (Loss of Smell)

    approved small molecule active

    1 trial
  8. Algorithm Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved small molecule completed

    1 trial
  9. Amodiaquine plus Artesunate co-administration

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  10. Amoxicillin/clavulanate

    GlaxoSmithKline

    Focal Infection, Dental

    approved small molecule completed

    1 trial
  11. Ampicillin

    Takeda

    Surgical Site Infection

    approved small molecule completed

    1 trial
  12. Antiretroviral therapy (ART)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial
  13. Artemether-lumefantrine combination

    United Therapeutics Europe Ltd

    Plasmodium Vivax Infection

    approved small molecule completed

    1 trial
  14. Artesunate-amodiaquine combination

    United Therapeutics Europe Ltd

    Malaria,Falciparum

    approved small molecule completed

    1 trial
  15. Athena strategy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved other active

    1 trial
  16. Azvudine

    The First People's Hospital of Lianyungang

    COVID-19

    approved small molecule active

    1 trial
  17. BIMERVAX LP.8.1 emulsion for injection COVID... for COVID-19 infection

    The George Institute

    COVID-19 infection

    approved small molecule active

    1 trial
  18. BV-2020/08

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections with Wheezing Lower Respiratory Illness

    approved small molecule active

    1 trial
  19. Biktarvy 50 mg/200 mg/25 mg film-coated tablets

    Gilead Sciences Pty Limited

    HIV-1 infection

    approved small molecule active

    1 trial
  20. CEFAZOLIN

    Pari Pharma GmbH

    Infection prophylaxis

    approved small molecule active

    1 trial
  21. CEFOSPROST

    The George Institute

    Acute bacterial prostatitis

    approved small molecule active

    1 trial
  22. COVAX

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    1 trial
  23. COVID-19 Vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  24. Ceftriaxon Fresenius Kabi poeder voor oplossi... for Sepsis

    Disc Medicine

    Sepsis

    approved small molecule active

    1 trial
  25. Chlorhexidine

    CRESCENT BIOPHARMA, INC.

    Neonatal Infections

    approved small molecule completed

    1 trial
  26. Chloroquine

    United Therapeutics Europe Ltd

    Malaria, Falciparum

    approved small molecule completed

    1 trial
  27. Ciprofloxacin

    Iterum Therapeutics plc

    UTI - Lower Urinary Tract Infection

    approved small molecule completed

    1 trial
  28. Citrate anticoagulation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial
  29. Coartem™ (Artemether-lumefantrine combination)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  30. Covid-19 vaccine (0-1-4 schedule)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    2 trials
  31. DAN-COVID

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial
  32. DAN-RSV

    Pfizer Australia Pty Ltd

    RSV-infection

    approved small molecule active

    1 trial
  33. Depo-Medroxyprogesterone Acetate

    United Therapeutics Europe Ltd

    HIV

    approved small molecule completed

    1 trial
  34. ETHINYL ESTRADIOL AND LEVOGESTREL

    United Therapeutics Europe Ltd

    HIV/AIDS

    approved small molecule completed

    1 trial
  35. Engerix-B 20 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved mab completed

    1 trial
  36. Engerix™ -B

    GlaxoSmithKline

    Hepatitis B

    approved mab completed

    1 trial
  37. Entecavir + Placebo

    ShuGuang Hospital

    Liver Cirrhosis Due to Hepatitis B Virus

    approved small molecule active

    1 trial
  38. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial
  39. Entecavir, Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial
  40. Experimental 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial
  41. Experimental 23-valent Pneumococcal

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial
  42. Experimental Group

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    4 trials
  43. Experimental vaccine 1

    Sinovac Research and Development Co.,

    COVID-19

    approved mab on hold

    1 trial
  44. FOSFOMYCIN

    The George Institute

    Uncomplicated urinary tract infection (uUTI)

    approved small molecule active

    1 trial
  45. FTC-TDF PrEP

    United Therapeutics Europe Ltd

    HIV Infection

    approved small molecule completed

    1 trial
  46. Ganciclovir

    Hoffmann-La Roche

    Cytomegalovirus Infections

    approved small molecule completed

    1 trial
  47. Gardasil 9 suspension for Evaluation of the reduction of…

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial
  48. HCV-001

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial

Frequently asked questions

How many infectious disease pipeline programs are tracked?

1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.